Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 3rd ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC | $88.76B | $43.69 | N/A | N/A | N/A | N/A | 2.33% | 29.58% | 107.53% | 26.84% | |||
| NVS | NOVARTIS AG | $249.96B | $129.12 | $118.00 | -8.61% | Strong Sell | 1 | 1.97% | 13.81% | 45.00% | 18.10% | |||
| BIIB | BIOGEN INC | $21.21B | $144.69 | $175.43 | 21.24% | Buy | 14 | -2.22% | 14.94% | 13.78% | 8.58% | |||
| GRFS | GRIFOLS SA | $6.50B | $9.45 | $10.30 | 8.99% | Hold | 1 | 8.76% | 128.42% | 17.25% | 4.74% | |||
| AZN | ASTRAZENECA PLC | $261.98B | $84.51 | N/A | N/A | N/A | N/A | 5.37% | 29.55% | 20.35% | 8.09% | |||
| AMRN | AMARIN CORP PLC | $396.49M | $19.17 | $12.00 | -37.40% | Strong Sell | 1 | -6.84% | N/A | -19.57% | -13.58% | |||
| LLY | ELI LILLY & CO | $775.53B | $819.40 | $896.38 | 9.39% | Strong Buy | 8 | 17.01% | 35.70% | 236.59% | 42.84% | |||
| JNJ | JOHNSON & JOHNSON | $459.75B | $190.90 | $190.77 | -0.07% | Buy | 13 | 3.93% | 8.93% | 40.54% | 16.45% | |||
| SNY | SANOFI | $123.28B | $48.80 | $58.00 | 18.85% | Strong Buy | 1 | 4.16% | 6.31% | 7.99% | 4.48% | |||
| GILD | GILEAD SCIENCES INC | $146.68B | $118.21 | $124.73 | 5.51% | Strong Buy | 11 | 3.06% | 22.14% | 64.73% | 22.85% | |||
| BMY | BRISTOL MYERS SQUIBB CO | $88.62B | $43.54 | $53.67 | 23.26% | Hold | 6 | -4.41% | 32.05% | 63.72% | 11.74% | |||
| ABBV | ABBVIE INC | $406.84B | $230.30 | $243.08 | 5.55% | Strong Buy | 13 | 7.15% | 97.18% | -17,126.44% | 22.85% | |||
| AMGN | AMGEN INC | $157.42B | $292.41 | $308.60 | 5.54% | Hold | 10 | 2.19% | 21.79% | 164.59% | 13.91% | |||
| OGN | ORGANON & CO | $2.50B | $9.60 | $14.00 | 45.83% | Buy | 2 | 0.38% | 20.07% | 151.44% | 8.22% | |||
| PFE | PFIZER INC | $140.60B | $24.73 | $27.40 | 10.80% | Hold | 5 | -1.54% | 17.36% | 17.12% | 7.37% | |||
| SCLX | SCILEX HOLDING CO | $102.53M | $14.74 | N/A | N/A | N/A | N/A | 34.46% | N/A | N/A | -183.13% | |||
| MRK | MERCK & CO INC | $214.06B | $85.70 | $95.50 | 11.44% | Hold | 6 | 3.86% | 15.94% | 51.92% | 21.64% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $24.50M | $1.29 | N/A | N/A | N/A | N/A | N/A | N/A | -1,371.99% | -900.41% | |||
| MDCX | MEDICUS PHARMA LTD | $41.33M | $2.32 | $23.50 | 912.93% | Strong Buy | 2 | N/A | N/A | -82.26% | -22.39% | |||
| NSRX | NASUS PHARMA LTD | N/A | $7.75 | $22.00 | 183.87% | Strong Buy | 1 | N/A | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.